Table 2. Antiprotozoal Malaria Box compounds with activity in biological assays and lacking toxicity at therapeutic levels.
Antiprotozoal positives | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Cryptosporidium parvum (SI>20) | Trypanosoma brucei (positive in all three screens, and SI >10) | T. cruzi (Scynexis screen) | T. cruzi (Maes screen) | Leishmania donovani amastigotes axenic (extracellular): | Toxoplasma gondii | Babesia spp. (3) AND Theileria equi | Babesia spp. (3) OR Theileria equi (excluding active on all 4 spp.) | Naegleria fowleri | Neospora caninum | Perkinsus marinus |
MMV665917p | MMV020505d | MMV006558p | MMV001230d | MMV000356d | MMV007363d | MMV006706d | MMV000620Bc | MMV665979d | MMV000911d | MMV666081d |
MMV020548d | MMV006706d | MMV007907d | MMV007907d | MMV007791d | MMV666093d | MMV000653Bbi+Bbo | MMV006309p | |||
MMV006764p | MMV011438p | MMV666095p | MMV396693p | MMV000911Bc | MMV019670d | |||||
MMV007571d | MMV019127d | MMV007881d | MMV073843p | MMV006764Bbo+Bbi | ||||||
MMV011256d | MMV665979d | MMV006704d | MMV665875p | MMV007374Bc | ||||||
MMV019199p | MMV665987p | MMV007557Bc+Bbi | ||||||||
MMV498479p | MMV666686p | MMV007808Bc | ||||||||
MMV665841p | MMV007906Bc | |||||||||
MMV665843d | MMV008173Bbo+Bbi | |||||||||
MMV665878d | MMV008455Bbi | |||||||||
MMV665890d | MMV011438Bbo+Bbi | |||||||||
MMV665899d | MMV018984Bc+Bbo | |||||||||
MMV665908p | MMV019199Bbo+Bbi | |||||||||
MMV019202Bc | ||||||||||
MMV019670Bc | ||||||||||
MMV019995Bbi | ||||||||||
MMV396681Bc | ||||||||||
MMV665878Bbi | ||||||||||
MMV665879Bbo+Bbi | ||||||||||
MMV665890Bbo+Bbi | ||||||||||
MMV665908Bbi+Bbo+Te | ||||||||||
MMV665939Bbo+Bbi | ||||||||||
MMV665946Te | ||||||||||
MMV666009Bc+Bbi | ||||||||||
MMV666025Bbo | ||||||||||
MMV666095Bc | ||||||||||
MMV666116Te+Bbi | ||||||||||
MMV666689Bbo+Bbi |